John J Lupica, the Vice Chrm of $CB, sold 2,907 shares of the company on 07-01-2025 for an estimated $843,233. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.0% of their shares of this class of stock. Following this trade, they now own 93,786 shares of this class of $CB stock.
$CB Insider Trading Activity
$CB insiders have traded $CB stock on the open market 19 times in the past 6 months. Of those trades, 1 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $CB stock by insiders over the last 6 months:
- JOHN W KEOGH (President & COO) has made 1 purchase buying 9,809 shares for an estimated $2,874,135 and 4 sales selling 94,876 shares for an estimated $27,563,599.
- JOSEPH F WAYLAND (Executive Vice President and*) has made 0 purchases and 3 sales selling 27,492 shares for an estimated $8,017,858.
- EVAN G GREENBERG (Chairman & CEO) has made 0 purchases and 2 sales selling 25,728 shares for an estimated $7,498,397.
- TIMOTHY ALAN BOROUGHS (Executive Vice President*) has made 0 purchases and 3 sales selling 14,748 shares for an estimated $4,367,248.
- JUAN LUIS ORTEGA (Executive Vice President*) sold 6,504 shares for an estimated $1,900,013
- JOHN J LUPICA (Vice Chrm, Chubb Group*) has made 0 purchases and 2 sales selling 5,513 shares for an estimated $1,599,077.
- GEORGE F. OHSIEK (Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,770 shares for an estimated $491,086.
- MICHAEL G ATIEH sold 538 shares for an estimated $154,707
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CB Hedge Fund Activity
We have seen 818 institutional investors add shares of $CB stock to their portfolio, and 862 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GQG PARTNERS LLC added 4,964,298 shares (+112.1%) to their portfolio in Q1 2025, for an estimated $1,499,168,353
- VIKING GLOBAL INVESTORS LP added 1,949,065 shares (+inf%) to their portfolio in Q1 2025, for an estimated $588,598,139
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,832,443 shares (-11.2%) from their portfolio in Q1 2025, for an estimated $553,379,461
- ONTARIO TEACHERS PENSION PLAN BOARD removed 1,423,181 shares (-99.9%) from their portfolio in Q1 2025, for an estimated $429,786,430
- WELLINGTON MANAGEMENT GROUP LLP removed 1,364,749 shares (-16.0%) from their portfolio in Q1 2025, for an estimated $412,140,550
- CASTLEKEEP INVESTMENT ADVISORS LLC removed 1,215,076 shares (-99.6%) from their portfolio in Q1 2025, for an estimated $366,940,801
- JPMORGAN CHASE & CO removed 974,003 shares (-15.4%) from their portfolio in Q1 2025, for an estimated $294,139,165
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CB Congressional Stock Trading
Members of Congress have traded $CB stock 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $CB stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 06/13.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 04/07, 02/14, 01/24.
- REPRESENTATIVE GEORGE WHITESIDES sold up to $250,000 on 03/24.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 01/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CB Analyst Ratings
Wall Street analysts have issued reports on $CB in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Strong Buy" rating on 04/24/2025
To track analyst ratings and price targets for $CB, check out Quiver Quantitative's $CB forecast page.
$CB Price Targets
Multiple analysts have issued price targets for $CB recently. We have seen 3 analysts offer price targets for $CB in the last 6 months, with a median target of $304.0.
Here are some recent targets:
- Brian Meredith from UBS set a target price of $304.0 on 04/28/2025
- Elyse Greenspan from Wells Fargo set a target price of $278.0 on 04/24/2025
- An analyst from HSBC set a target price of $323.0 on 03/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
